Clinical Trial

Artificial Intelligence (AI)-Enhanced Pretreatment Peer-review Process to Improve Patient Safety in Radiation Oncology

Recruiting
View on ClinicalTrials.gov →
Summary
This prospective study will test artificial intelligence (AI) and machine learning (ML) decision support tools. This tool is designed to help doctors, physicists and other staff during pre-treatment peer review, a step where treatment plans are checked before a patient begins care. The system highlights summaries showing how different providers may vary in their treatment planning (provider-variability summaries) and points out the best signals or warning signs to look for (optimal cues). By drawing attention to these patterns and cues, the tool aims to help reviewers spot possible treatment-planning mistakes earlier, reduce the chance of errors, and improve overall patient safety.
Protocol Amendment History 1 change
critical Recruitment opened 2026-06-24
Trial Details
NCT Number NCT07463833
Lead Sponsor UNC Lineberger Comprehensive Cancer Center
Collaborators: Agency for Healthcare Research and Quality (AHRQ)
Conditions Cancer, Prostate Cancer
Enrollment 207 participants
Start Date 2026-06-22
Primary Completion 2027-07 (estimated)
Study Completion 2027-07 (estimated)
Updated on ClinicalTrials.gov 2026-06-23